REQUEST A DEMO
Total
USD $0.00
Search more companies

HETKORONA Kft. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: HETKORONA Kft. Profile Updated: September 26, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Hungarian Download a sample report

HETKORONA Kft. is a company in Hungary, with a head office in Budapest. The company operates in the Pharmacies and Drug Stores industry. It was established on February 01, 1991. 13 (2024) employees currently work for HETKORONA Kft.. In its most recent financial highlights, the company reported a net sales revenue increase of 13.08% in 2024. Its’ total assets recorded a growth of 19.75%. HETKORONA Kft.’s net profit margin increased by 3.87% in 2024.

Headquarters
Chazar Andras u. 14.
Budapest; Budapest; Postal Code: 1146

Contact Details: Purchase the HETKORONA Kft. report to view the information.

Basic Information
Total Employees:
Purchase the HETKORONA Kft. report to view the information.
Registered Capital:
Purchase the HETKORONA Kft. report to view the information.
Financial Auditors:
Purchase the HETKORONA Kft. report to view the information.
Incorporation Date:
February 01, 1991
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
CSENGO-KORONA Bt.
Lurdy-Korona Kft.
Zengo-Korona Bt.
Company Performance
Financial values in the chart are available after HETKORONA Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
13.08%
Total operating revenue
13.04%
Operating profit (EBIT)
85.16%
EBITDA
82.07%
Net Profit (Loss) for the Period
85.44%
Total Assets
19.75%
Total Equity
22.89%
Operating Profit Margin (ROS)
3.77%
Net Profit Margin
3.87%
Return on Equity (ROE)
13.24%
Quick Ratio
0.29%
Cash Ratio
0.44%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?